Is BPC 157 Legal? Understanding Its Status and Implications Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, BPC TB 5 Beverly Hills Rejuvenation Center The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization FDA to weigh easing limits on unproven peptides